Advertisement
U.S. markets open in 3 hours 1 minute

Standard BioTools Inc. (LAB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
2.5900-0.0300 (-1.15%)
At close: 04:00PM EDT
2.6100 +0.02 (+0.77%)
After hours: 04:20PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Double Moving Average Crossover

Double Moving Average Crossover

Previous Close2.6200
Open2.6100
Bid2.6600 x 2900
Ask2.7600 x 3100
Day's Range2.5800 - 2.6700
52 Week Range1.4600 - 3.1600
Volume1,281,551
Avg. Volume1,818,128
Market Cap751.406M
Beta (5Y Monthly)1.62
PE Ratio (TTM)N/A
EPS (TTM)-0.9400
Earnings DateMay 07, 2024 - May 13, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est0.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for LAB

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Standard BioTools Inc.
    Daily – Vickers Top Buyers & Sellers for 03/07/2024The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    12 days agoArgus Research
View more
  • GlobeNewswire

    Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock

    SOUTH SAN FRANCISCO, Calif., March 18, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (“Standard BioTools” or the “Company”) (Nasdaq: LAB) today announced that it has exchanged all outstanding shares of its Series B Convertible Preferred Stock (the “Series B Preferred”) for shares of common stock pursuant to an agreement with stockholders affiliated with Viking Global Investors (“Viking”) and Casdin Capital (“Casdin"). Thomas Carey, Chairman of the Standard BioTools Board of Directors, said, “W

  • Insider Monkey

    Standard BioTools Inc. (NASDAQ:LAB) Q4 2023 Earnings Call Transcript

    Standard BioTools Inc. (NASDAQ:LAB) Q4 2023 Earnings Call Transcript February 28, 2024 Standard BioTools Inc. beats earnings expectations. Reported EPS is $-0.08, expectations were $-0.13. LAB isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, everyone, and welcome to […]

  • Simply Wall St.

    Standard BioTools Full Year 2023 Earnings: Revenues Beat Expectations, EPS In Line

    Standard BioTools ( NASDAQ:LAB ) Full Year 2023 Results Key Financial Results Revenue: US$106.3m (up 8.6% from FY...